Abbott Laboratories vs. Travere Therapeutics, Inc. Common Stock
ABT
Abbott Laboratories
$113.60 -1.65%
VS TVTXTravere Therapeutics, Inc. Common Stock
$52.45 +6.16%
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | TVTX | |
|---|---|---|
| Market Cap | $199.88 billion | $4.66 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | TVTX | |
|---|---|---|
| Dividend Yield | 2.22% | — |
ABT and TVTX split the dividend factors evenly.
Risk & Sentiment
| ABT | TVTX | |
|---|---|---|
| Short Interest | 0.57% | 4.98% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, TVTX overview, TVTX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
